Related Experiment Videos
[Multiple endocrine neoplasia]
Hiroshi Takami1, Yoshifumi Ikeda, Kaori Kameyama
1Department of Surgery, Teikyo University School of Medicine, 2-11-1 Kaga, Itabashi-ku, Tokyo 173-8605, Japan.
Gan to Kagaku Ryoho. Cancer & Chemotherapy
|April 30, 2002
Summary
Multiple Endocrine Neoplasia (MEN) syndromes involve tumors in multiple endocrine glands. Genetic identification allows for early diagnosis and management of MEN 1 and MEN 2.
Area of Science:
- Endocrinology
- Genetics
- Oncology
Background:
- Multiple Endocrine Neoplasia (MEN) syndromes are inherited endocrine disorders characterized by tumors in two or more endocrine glands.
- These syndromes are classified as MEN 1 and MEN 2, each associated with specific combinations of endocrine tumors.
- MEN syndromes are inherited in an autosomal dominant pattern.
Purpose of the Study:
- To discuss the diagnosis and treatment of Multiple Endocrine Neoplasia (MEN) syndromes.
- To highlight the genetic basis of MEN 1 and MEN 2.
- To emphasize the importance of early diagnosis through familial screening.
Main Methods:
- Identification of genes responsible for MEN syndromes.
- Localization of the MEN 1 gene (tumor suppressor gene for menin) to chromosome 11q.
- Identification of the RET proto-oncogene mutation on chromosome 10q as the cause of MEN 2.
Main Results:
- The genetic underpinnings of MEN 1 and MEN 2 have been elucidated.
- MEN 1 is associated with a tumor suppressor gene on chromosome 11.
- MEN 2 is caused by mutations in the RET proto-oncogene on chromosome 10.
Conclusions:
- Genetic identification enables early diagnosis of MEN syndromes via familial screening.
- Understanding the specific genes (menin for MEN 1, RET for MEN 2) is crucial for diagnosis.
- Effective management strategies for MEN syndromes rely on accurate diagnosis and genetic information.